Negatively charged polymer-shielded supramolecular nano-micelles with stimuli-responsive property for anticancer drug delivery. 2022

Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
State Key Laboratory of Applied Organic Chemistry, Institute of Biochemical Engineering & Environmental Technology, College of Chemistry and Chemical Engineering, Lanzhou University, 222 Tianshui Road, Lanzhou 730000, PR China; Gansu Food Inspection and Research Institute, Lanzhou 730300, PR China.

A new kind of negatively charged polymer-shielded supramolecular nano-micelles with dual-responsive property was designed for tumor treatment, which was prepared on the basis of adamantane terminated linear PAsp(DIP) and disulfide-β-cyclodextrin-terminated PAsp(EDA). The supramolecular nano-micelles comprised a 2,3-dimethylmaleic anhydride (DA) protective layer to stabilize the micelles, a pH-responsive core to package hydrophobic model drugs, and a disulfide-crosslinked interlayer to shackle the core against drug leakage under normal physiological conditions. After arriving at the tumor tissue via EPR, the targeting function could be turned on by dislodging DA groups on the surface of micelles, which allowed the drug-loaded nano-micelles to be easily phagocytized by the tumor cells, and then release the drug inside the cells induced by the increased glutathione level and acidic pH. The results indicated that the charge-conversional dual-responsive supramolecular nano-micelles showed excellent antitumor activity.

UI MeSH Term Description Entries
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000218 Adamantane A tricyclo bridged hydrocarbon. Diamantane
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D047392 beta-Cyclodextrins Cyclic GLUCANS consisting of seven (7) glucopyranose units linked by 1,4-glycosidic bonds. beta Cyclodextrins

Related Publications

Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
November 2011, Journal of controlled release : official journal of the Controlled Release Society,
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
September 2015, Journal of controlled release : official journal of the Controlled Release Society,
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
December 2022, Chemistry (Weinheim an der Bergstrasse, Germany),
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
June 2020, Journal of controlled release : official journal of the Controlled Release Society,
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
January 2018, International journal of nanomedicine,
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
September 2015, Journal of biomedical materials research. Part A,
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
December 2020, Journal of drug targeting,
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
June 2018, Advanced healthcare materials,
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
May 2020, Molecular pharmaceutics,
Juanjuan Yin, and Jianrong Wang, and Xue Dong, and Congshu Huang, and Hua Wei, and Guanghui Zhao
September 2014, Biomacromolecules,
Copied contents to your clipboard!